Justin Stindt Consultants is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industries.
Our agency is passionate about enabling patient access to innovative medicines and technologies. We are a service provider to pharma, biotech, medtech and e-health clients, helping to determine what clinical evidence payers will need to see in order to grant reimbursement at a sustainable price. Our team of experts leverages secondary research e.g. in Pricing & Reimbursement databases, primary research with payers and clinical experts and our agency’s experience from hundreds of Market Access projects.
Our market access consultancy firm has extensive international experience in all major EU markets, the US, Japan and selected emerging markets. Our team of experts operates from offices in Paris, Cologne and Zug and has a global reach through our network of payers, clinical experts and partners.
As a leading pharmaceutical market access consulting agency, we provide comprehensive support across all stages of product development and commercialization.
Would you like to know what our customers are saying about us?
Then have a look at our client testimonials and you will find attributes such as commitment to excellence, trusted partnerships, flexible and customized support, expert knowledge and our extensive network all engaged to enable Market Access for our client’s products.
Meet selected experts within our global team
We mobilize project teams of 50+ market access consultancy specialists
Justin Stindt
Founder and Managing Director
Justin is an experienced Market Access strategist with a background at GlaxoSmithKline and in consulting. Justin supports pharma, biotech and medtech clients with Market Access strategy and execution. He has led hundreds of Pricing & Reimbursement projects, overseen development of Pricing & Reimbursement dossiers, led engagements with HTA bodies and conducted price negotiations on behalf of clients. Justin is fluent in English, French, German, and Spanish.
Javier Arribas Díaz
Partner
With a focus on orphan drugs, Javier is experienced in advising pharmaceutical and medtech clients on market access and pricing strategies. Javier is both leading global projects and activities focused on the Spanish market such as the development of Spanish Pricing & Reimbursement strategies and dossiers. Javier has prior consulting experience at Accenture and Werfen. He studied at Kellogg School of Management in the US, did an MBA at IESE in Spain, and is proficient in Spanish and English.
Anne Stindt
Director
Anne is a health insurance specialist with a background in digital marketing and health and medical insurance purchasing at AXA where she held roles both on corporate level in the headquarter in Paris and on affiliate level in Germany. At Justin Stindt Consultants, she leads global research projects and develops Pricing & Reimbursement strategies. She is fluent in French, English, German and Portuguese and holds a Master’s degree from ESCP-EAP Business School.
Jesús Arribas
Chief Financial Officer
Jesús Arribas is a finance expert with extensive experience as a Chief Financial Officer and Management Consultant. He has led the creation and optimization of finance departments, developed long-term strategies, and improved accounting processes. His ability to advise on financial projections and audits has been key to the success of multiple companies.
Eva Brčić
Senior Consultant
Eva specializes in strategic market access research for pharmaceutical and biotech firms. Her projects include pricing and reimbursement analysis, research in medical information and Pricing & Reimbursement databases, and expert interviews with payers and clinical experts. Eva is fluent in English, French, and Croatian and has a Master in Management and a Bachelor’s in Psychology from the Erasmus University Rotterdam.
Joaquim Knox
Senior Consultant
Joaquim Knox is a senior consultant with a strong foundation in biochemistry with experience in drug development and business development in the pharmaceutical industry. Holding a Bachelor’s degree in Biological Sciences, with emphasis in Biochemistry, from UNIRIO, and a Masters degree in Pharma and Biotech Management from EADA Business School, Joaquim focuses on developing strategic Pricing and Reimbursement strategies for pharmaceutical and biotech companies. With a background spanning from preclinical strategy to clinical development in different therapeutic fields, such as Urology, Ophthalmology, Respiratory and Orphan Drugs, Joaquim brings valuable insights into the intricacies of drug development. Additionally, his work in Business Development and Licensing roles across the pharma and biotech industry, enhances his ability to navigate complex market landscapes. Joaquim is proficient in Portuguese, English and Spanish.
Matteo Brunelli
Consultant
Matteo focuses on Market Access and Pricing & Reimbursement strategies for pharmaceutical and biotech companies. His work combines market access research with quantitative analysis, covering pricing and reimbursement landscapes, benchmarking, and payer and HTA environments across European markets. He holds a bachelor’s degree in Economics and Finance from Bocconi University and is currently completing a master’s degree in Accounting, Financial Management and Control. Matteo is a native Italian speaker and is fluent in English.
Matteo Proietti
Consultant
Matteo supports Market Access research for pharmaceutical and biotech companies, bringing a quantitative and business-oriented perspective through his background in finance, valuation, and data analysis. He holds a bachelor’s degree in Economics and Finance from Bocconi University and is currently completing a master’s degree in Accounting, Financial Management and Control. Matteo is a native Italian speaker and is fluent in English and French.
Charlotte Guillemot
Consultant
Charlotte specialises in Pricing and Reimbursement, and Market Access strategies for pharmaceutical and biotech companies. She supports projects focused on pricing, statutory rebates, and commercial agreements between manufacturers and payers across the EU-5. She holds a master’s degree in Biotech & Pharmaceutical Management from University College London (UCL) and is fluent in English and French.
Iliya Khanbani
Consultant
Iliya is a Consultant focusing on market access and Pricing & Reimbursement strategies for pharmaceutical and biotech companies. His project experience includes early access programmes, HTA assessments, indication prioritization, and strategic market research across the US and major European markets. He holds a bachelor’s degree in Mechanical Engineering and a Master in Management with a major in Economics and Finance from HEC Paris. He speaks English and French.
Nabil Abu Moamar
Consultant
Nabil has experience in strategy and commercial due diligence, including M&A due diligence, sell-side divestments, and international market entry projects. He holds a bachelor’s degree in Economics and Finance and a master’s degree in Accounting and Finance from Bocconi University, with international study experience in Oslo and Porto. He speaks Italian, English, and Spanish.
Miroslava Jurcova
Sales Operations Assistant & Executive Support to the CEO
Miroslava supports sales operations and provides executive support to the CEO, focusing on commercial coordination, CRM management, business development, and executive organisation. Her professional background spans marketing, client relations, and executive assistance, including experience in the pharmaceutical sector, where she supported marketing activities and senior management. She holds a degree from the Business Academy, with a focus on marketing and accounting, and is fluent in Slovak, Czech, French, and English.